Krystal Biotech, Inc. KRYS Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s interest coverage?
- Krystal Biotech, Inc. (KRYS) reported interest coverage of 6.2× in Q1 2026.
- How has Krystal Biotech, Inc.'s interest coverage changed year-over-year?
- Krystal Biotech, Inc.'s interest coverage increased by 68.3% year-over-year, from 3.7× to 6.2×.
- What is the long-term trend for Krystal Biotech, Inc.'s interest coverage?
- Over 2 years (2021 to 2025), Krystal Biotech, Inc.'s interest coverage has grown at a -64.7% compound annual growth rate (CAGR), from -45.8× to 5.7×.
- What does interest coverage mean?
- How many times the company's operating profit covers its interest bill.
- How do you interpret interest coverage?
- Higher is safer; below ~2× is a warning that earnings provide little cushion against the debt burden. Debt-free companies have no interest expense and the ratio is left blank.
- How does interest coverage compare across companies?
- Comparable across leveraged non-financials; less relevant for net-cash companies with negligible interest.